北陆药业
(300016)
| 流通市值：33.89亿 | | | 总市值：33.94亿 |
| 流通股本：4.91亿 | | | 总股本：4.92亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 281,772,393.85 | 473,326,698.53 | 542,178,797.23 | 748,445,988.82 |
| 应收票据及应收账款 | 156,555,006.69 | 184,440,387.05 | 171,136,084.87 | 188,551,107.92 |
| 其中：应收票据 | 2,174,799.46 | 1,355,958.3 | 4,325,347.9 | 3,507,825.11 |
| 应收账款 | 154,380,207.23 | 183,084,428.75 | 166,810,736.97 | 185,043,282.81 |
| 预付款项 | 25,077,962.62 | 14,441,346.35 | 21,328,885.91 | 7,207,116.04 |
| 其他应收款合计 | 1,891,584.36 | 785,900.67 | 2,415,012.59 | 1,743,076.65 |
| 存货 | 323,934,232.06 | 309,484,858.65 | 251,763,898.77 | 244,859,077.9 |
| 一年内到期的非流动资产 | 117,729.47 | 116,501.91 | - | - |
| 其他流动资产 | 7,460,734.67 | 10,511,576.5 | 4,611,752.67 | 5,985,720.81 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,213,615,397.43 | 1,270,107,269.66 | 1,253,434,432.04 | 1,196,792,088.14 |
| 非流动资产: | | | | |
| 长期应收款 | 1,680,043.78 | 1,662,526.09 | - | - |
| 长期股权投资 | 197,251,845.36 | 197,731,740.57 | 197,030,441.99 | 200,916,541.64 |
| 其他权益工具投资 | 100,000 | 100,000 | 100,000 | 100,000 |
| 其他非流动金融资产 | 343,995,912.51 | 348,416,307.91 | 352,714,182.96 | 355,045,125.09 |
| 固定资产 | 905,335,894.8 | 818,665,369.07 | 742,310,278.13 | 755,884,073.48 |
| 在建工程 | 56,200,335.18 | 139,715,218.57 | 114,200,287.75 | 110,390,908.52 |
| 生产性生物资产 | 5,884,554.22 | 6,132,209.95 | - | - |
| 使用权资产 | 8,395,770.62 | 9,688,662.78 | 9,235,535.85 | 9,951,899.12 |
| 无形资产 | 164,659,320.42 | 169,457,104.89 | 123,415,965.15 | 128,388,915.75 |
| 商誉 | 46,924,655.17 | 46,924,655.17 | - | - |
| 长期待摊费用 | 20,859,820.15 | 16,279,237.04 | 16,737,035.33 | 17,195,004.91 |
| 递延所得税资产 | 32,580,976.92 | 33,154,506.55 | 34,718,755.89 | 41,379,991.53 |
| 其他非流动资产 | 13,189,982.62 | 9,717,446.36 | 25,956,345.84 | 3,379,499.78 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,797,059,111.75 | 1,797,644,984.95 | 1,616,418,828.89 | 1,622,631,959.82 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,010,674,509.18 | 3,067,752,254.61 | 2,869,853,260.93 | 2,819,424,047.96 |
| 流动负债: | | | | |
| 短期借款 | 190,304,423.34 | 243,381,504.94 | 192,061,954.63 | 175,563,188.54 |
| 交易性金融负债 | 11,576,158.6 | 11,332,113.71 | 10,582,459.41 | 11,165,624.42 |
| 应付票据及应付账款 | 156,611,746.11 | 162,206,046.86 | 109,865,161.58 | 115,124,521 |
| 其中：应付票据 | 56,353,383.43 | 68,078,367.27 | 39,558,521.82 | 20,067,003.81 |
| 应付账款 | 100,258,362.68 | 94,127,679.59 | 70,306,639.76 | 95,057,517.19 |
| 合同负债 | 5,279,784.17 | 3,175,148.38 | 2,754,243.15 | 2,013,300.87 |
| 应付职工薪酬 | 15,899,179.95 | 15,629,854.04 | 13,657,162.68 | 26,624,270.62 |
| 应交税费 | 4,041,564.98 | 11,384,574.23 | 4,273,195.19 | 2,995,651.64 |
| 其他应付款合计 | 23,801,681.82 | 24,718,971.96 | 14,256,741.55 | 9,481,604.66 |
| 一年内到期的非流动负债 | 39,302,525.8 | 34,069,036.56 | 20,319,420.48 | 16,056,117.75 |
| 其他流动负债 | 437,143.76 | 127,636.28 | 255,749.82 | 145,579.08 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 447,254,208.53 | 506,024,886.96 | 368,026,088.49 | 359,169,858.58 |
| 非流动负债: | | | | |
| 长期借款 | 141,888,000 | 151,100,000 | 152,550,000 | 129,950,000 |
| 应付债券 | 489,873,226.89 | 480,496,426.37 | 471,440,711.07 | 462,598,092.67 |
| 租赁负债 | 5,625,996.85 | 6,376,866.97 | 5,650,232.55 | 7,169,445.43 |
| 递延收益 | 11,788,668.23 | 12,024,758.94 | 12,775,848.78 | 11,740,838.66 |
| 递延所得税负债 | 66,239,313.63 | 68,934,930.9 | 60,109,356.71 | 62,483,577.21 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 715,415,205.6 | 718,932,983.18 | 702,526,149.11 | 673,941,953.97 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,162,669,414.13 | 1,224,957,870.14 | 1,070,552,237.6 | 1,033,111,812.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 491,935,176 | 491,935,176 | 491,935,061 | 491,934,843 |
| 其他权益工具 | 112,593,376.73 | 112,593,376.73 | 112,593,642.04 | 112,594,146.13 |
| 资本公积 | 135,224,094.88 | 135,224,094.88 | 135,222,984 | 135,220,917.12 |
| 其他综合收益 | -2,434,914.92 | -2,434,914.92 | -2,434,914.92 | -2,434,914.92 |
| 专项储备 | 3,376,294.96 | 2,575,012.75 | 1,600,109.66 | 508,248.22 |
| 盈余公积 | 147,763,425.62 | 147,763,425.62 | 147,763,425.62 | 147,763,425.62 |
| 未分配利润 | 789,994,000.73 | 784,571,937.94 | 776,556,896.69 | 765,030,731.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,678,451,454 | 1,672,228,109 | 1,663,237,204.09 | 1,650,617,396.86 |
| 少数股东权益 | 169,553,641.05 | 170,566,275.47 | 136,063,819.24 | 135,694,838.55 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,848,005,095.05 | 1,842,794,384.47 | 1,799,301,023.33 | 1,786,312,235.41 |
| 负债和股东权益合计 | 3,010,674,509.18 | 3,067,752,254.61 | 2,869,853,260.93 | 2,819,424,047.96 |
| 公告日期 | 2024-10-30 | 2024-08-28 | 2024-04-22 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |